Login to Your Account

Corixa, Genesis Get Expected' Phase II PVAC Trial Results

By Kim Coghill

Friday, November 8, 2002
Corixa Corp. and its research partner, Genesis Research and Development Corp. Ltd., on Thursday released data from overseas trials of the injectable psoriasis treatment, PVAC, showing clinical activity and safety but a missed endpoint. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription